Menard Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$869K Buy
1,951
+169
+9% +$75.2K 0.52% 40
2025
Q1
$802K Buy
1,782
+152
+9% +$68.4K 0.53% 42
2024
Q4
$656K Buy
1,630
+187
+13% +$75.3K 0.39% 54
2024
Q3
$671K Buy
+1,443
New +$671K 0.44% 54